Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125671961 | 12567196 | 1 | I | 20160713 | 20160718 | 20160718 | EXP | US-ABBVIE-16P-163-1675808-00 | ABBVIE | 0.00 | A | F | Y | 0.00000 | 20160718 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125671961 | 12567196 | 1 | PS | CREON | PANCRELIPASE AMYLASEPANCRELIPASE LIPASEPANCRELIPASE PROTEASE | 1 | Oral | U | UNKNOWN | 20725 | |||||||||
| 125671961 | 12567196 | 2 | SS | REGLAN | METOCLOPRAMIDE HYDROCHLORIDE | 1 | Unknown | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125671961 | 12567196 | 1 | Dyspepsia |
| 125671961 | 12567196 | 2 | Dyspepsia |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125671961 | 12567196 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125671961 | 12567196 | Anxiety | |
| 125671961 | 12567196 | Depression | |
| 125671961 | 12567196 | Muscle spasms | |
| 125671961 | 12567196 | Musculoskeletal stiffness | |
| 125671961 | 12567196 | Pancreatic carcinoma stage IV | |
| 125671961 | 12567196 | Quality of life decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |